Results 191 to 200 of about 7,481 (249)

[Severe congenital Factor VII deficiency discovered incidentally in the peripartum period: a case report]. [PDF]

open access: yesPan Afr Med J
Aarjouni Y   +8 more
europepmc   +1 more source

Topical tranexamic acid in mastectomies on haematoma formation: prospective cohort study. [PDF]

open access: yesBJS Open
Buheiri AR   +5 more
europepmc   +1 more source

The plasmin inhibition by synthetic antifibrinolytic agents in relation to the type of substrate

open access: closedBiochimica et Biophysica Acta (BBA) - Enzymology, 1968
The inhibitory effect of synthetic antifibrinolytic agents: e-aminocaproic acid, p-aminomethyl benzoic acid and the active isomer of 1,4-aminomethyl cyclohexane carboxylic acid on plasmin (EC 3.4.4.14), acting on various substrates, was studied. All the inhibitors had a very weak effect, if any at all, on casein and fibrinogen proteolysis by plasmin ...
Hanna Łukasiewicz   +3 more
openalex   +4 more sources

Pharmacological agents: antifibrinolytics and desmopressin

Best Practice & Research Clinical Anaesthesiology, 2010
This article provides an overview of the scientific evidence regarding the efficacy and safety of antifibrinolytic agents and desmopressin to reduce surgical blood loss. The synthetic derivatives of lysine are the only antifibrinolytics available in clinical practice since the withdrawal of aprotinin.
Yves Ozier, Lorenn Bellamy
openaire   +3 more sources

The effect of antifibrinolytic agents on wound healing

International Journal of Oral and Maxillofacial Surgery, 1988
The effect on the tensile strength of healing wounds of 2 of the most commonly used antifibrinolytic substances, tranexamic acid and epsilon-aminocaproic acid, has been studied in white rats. 2 symmetrical linear lines were made on the dorsal skin, in 1 of which was injected 1 ml of the test solution. The incisions were closed with interrupted sutures,
Gunnar Björlin, Inga Marie Nilsson
openaire   +2 more sources

Human Placental Transfer of an Antifibrinolytic Agent (AMCA)

Acta Obstetricia et Gynecologica Scandinavica, 1970
Abstract. A fibrinolytic inhibitor AMCA (trans p‐aminomethyl cyclohexane carboxylic acid) was given i.v. in a dose of 0.01 g/kg bodyweight to 12 mothers about to be delivered by Caesarean section. Immediately after delivery the concentration of AMCA was determined in the maternal blood and in cord blood.
Inga Marie Nilsson, Stig Kullander
openaire   +3 more sources

Cimetidine—an Antifibrinolytic Agent?

Scandinavian Journal of Gastroenterology, 1983
The mucosal fibrinolytic activity was estimated in 14 patients with duodenal ulcer before and after 4 weeks' treatment with cimetidine. A significant reduction in fibrinolytic activity in the corpus and antrum mucosa was found after treatment. In patients with healed ulcer after treatment, the activity was lower than in patients with unhealed ulcers ...
openaire   +3 more sources

Antifibrinolytic agents in subarachnoid haemorrhage

Journal of Neurology, 1987
For many years clinicians have used antifibrinolytic agents to try to reduce rebleeding after subarachnoid haemorrhage. Early studies of their effectiveness produced conflicting results. This paper re-evaluates the available trials and considers benefits in the light of potential complications.
openaire   +2 more sources

The effect of antifibrinolytic agents on wound healing in vitro

Experientia, 1977
The effect of antifibrinolytic agents (antiplasminogen activators) on wound healing was studied in vitro. All these substances caused the proliferating epithelium to change direction and migrate to stratum corneum, resulting in a everted epiboly formation.
L. Hänström   +2 more
openaire   +3 more sources

Home - About - Disclaimer - Privacy